Delhi High Court delivers verdict in favour of Mankind Pharma in a trademark infringement case against Sepkind Pharma.

The Delhi High Court has ruled in favor of Mankind Pharma, a leading pharmaceutical company, in a trademark infringement case against Sepkind Pharma. The court held that Sepkind Pharma’s use of the trademark “Sepkind” was likely to deceive or cause confusion among customers, and thus, violated Mankind Pharma’s registered trademark “Septran”. Sepkind Pharma had allegedly been using the mark “Sepkind” for its antibiotic products, which are similar to Mankind Pharma’s products bearing the “Septran” mark. The court observed that both marks are phonetically similar and have a similar structure, which could lead to confusion among customers. As a result, the court granted an injunction in favor of Mankind Pharma, restraining Sepkind Pharma from using the mark “Sepkind” or any similar mark. The court also directed Sepkind Pharma to recall and destroy all infringing products and materials bearing the mark “Sepkind”. This ruling is a significant victory for Mankind Pharma, as it protects its intellectual property rights and reputation in the market.